Efficacy and safety of venetoclax combined with hypomethylating agents for relapse of acute myeloid leukemia and myelodysplastic syndrome post allogeneic hematopoietic stem cell transplantation: a systematic review and meta-analysis

Abstract Background Currently, there is no standard treatment for managing relapse in patients with acute myeloid leukemia and myelodysplastic syndrome (AML/MDS) after allogeneic hematopoietic cell transplantation. Venetoclax-based therapies have been increasingly used for treating post-transplantat...

Cur síos iomlán

Sonraí bibleagrafaíochta

Príomhchruthaitheoirí:	Yufeng Du, Chunhong Li, Zhijia Zhao, Yikun Liu, Chengtao Zhang, Jinsong Yan
Formáid:	Artigo
Teanga:	Inglês
Foilsithe / Cruthaithe:	BMC 2023-08-01
Sraith:	BMC Cancer
Ábhair:	Acute myeloid leukemia Myelodysplastic syndrome Venetoclax Hypomethylating agents Allogeneic hematopoietic cell transplantation Relapse
Rochtain ar líne:	https://doi.org/10.1186/s12885-023-11259-6
Clibeanna:	Cuir clib leis Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!